What does Royalty Pharma plc do?
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such…
What is Royalty Pharma plc's P/E and P/B ratio?
Royalty Pharma plc has a P/E ratio of 33.9 and a P/B ratio of 5.39.
What is Royalty Pharma plc's debt-to-equity ratio?
Royalty Pharma plc has a debt-to-equity ratio of 0.92.
How much does Royalty Pharma plc owe compared with what it owns?
Royalty Pharma plc owes $0.51 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Royalty Pharma plc's Positivity rank?
Royalty Pharma plc is ranked #5,375 of 6,775 companies globally and #2,903 of 4,000 in United States on PositoAI, with a Positivity Score of 17,663.
Does Royalty Pharma plc have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Royalty Pharma plc.
Where can I read the latest news about Royalty Pharma plc?
Recent headlines about Royalty Pharma plc from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Royalty Pharma plc have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Royalty Pharma plc's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.